High-throughput screening: Advances in assay technologies

Current Opinion in Chemical Biology

Volumn 1, Issue 3, 1997, Pages 384-391

  Sittampalam, G Sitta ^a   Kahl, Steven D ^a   Janzen, William P ^b  

^a ELI LILLY AND COMPANY   (United States)

^b Sphinx Pharmaceuticals Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

COLORIMETRY; DRUG DESIGN; ENERGY TRANSFER; METHODOLOGY; RADIOCHEMISTRY; REVIEW; SPECTROFLUOROMETRY;

COLORIMETRY; DRUG DESIGN; ENERGY TRANSFER; PHARMACEUTICAL PREPARATIONS; RADIOCHEMISTRY; SPECTROMETRY, FLUORESCENCE;

EID: 0031244338     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(97)80078-6     Document Type: Article

References (69)

1. Oliver SG: From DNA sequence to biological function. Nature 1996, 379:597-600.
2. Baum R: Combinatorial chemistry. Chem Eng News, February 12, 1996:28-54.
3. Broach JR, Thorner J: High throughput screening for drug discovery. Nature 1996, 384:14-16. This is an excellent overview of high-throughput screening (HTS) with its advantages and disadvantages in early drug discovery. A good account of problems encountered with in vitro and cell-based assays are also given. Future developments in HTS are concisely documented.
4. Janzen WP: High throughput screening as a discovery tool in the pharmaceutical industry. Lab Robotics Automation 1996, 8:261-265. An industrial perspective on steps leading up to the implementation of high-throughput screening is given in this paper. Topics covered include organizational interactions, the screening paradigm employed, and how assays are converted to screens.
5. Fernandes PB: Letter from the society president. J Biomol Screening 1997, 2:1.
6. Burbaum JJ, Sigal NH: New technologies for high-throughput screening. Curr Opin Chem Biol 1997, 1:72-78. An excellent review of new technologies for high-throughput screening. The paper contains references on nonradioactive assay technologies, screening methods for combinatorial libraries and issues associated with assay miniaturization.
7. Sittampalam GS, Iversen PW, Boadt JA, Kahl SD, Bright S, Zock JM, Janzen WP, Lister MD: Design of signal windows in high throughput screening assays for drug discovery. J Biomol Screening 1997, 2:159-169. This paper describes the concept of signal windows, which provides a degree of separation between measured signals. The size of the signal window is a critical performance parameter (in high-throughput screens) which impacts the identification of active compounds ('hits') in the presence variability.
8. Hook D: Ultra high throughput screening - a journey into Nanoland with Gulliver and Alice. Drug Discov Tech 1996, 1:267-268.
9. Braunwalder AF, Wennogle L, Gay B, Lipson KE, Sills MA: Application of scintillation microtiter plates to measure phosphopeptide interactions with GRB2-SH2 binding domain. J Biomol Screening 1996, 1:23-26.
10. Cole JL: Approaches to high volume screening assays of viral polymerases and related proteins. Methods Enzymol 1996, 275:310-328.
11. Cook ND: Scintillation proximity assay: a versatile high throughput screening technology. Drug Discov Tech 1996, 1:287-294. A good account of the basic principles of the scintillation proximity assay and its specific applications in high-throughput screening, with 70 references cited.
12. 1E receptor binding activity. J Biomol Screening 1997, 2:33-40. This paper describes the development of a scintillation proximity assay for receptor binding studies in high-throughput mode. Validation concepts and factors affecting robustness of the assays in high-throughput screening mode are addressed in detail.
13. Lerner CG, Chiang Saiki AY, Mackinnon CA, Xuei X: High throughput screen for inhibitors of bacterial DNA topoisomerase I using scintillation proximity assay. J Biomol Screening 1996, 1:135-143.
14. Baker CA, Poorman RA, Kezdy FJ, Staples DJ, Smith CW, Elhammer AP: A scintillation proximity assay for UDP-GalNAc:polypeptide, N-Acetylgalactosaminyltransferase. Anal Biochem 1996, 239:20-24.
15. 33P as a label in a scintillation proximity assay system. The authors demonstrate the utility of a simple 'mix and measure' assay to screen for protease inhibitors.
16. Sullivan E, Hemsley P, Pickard A: Development of a scintillation proximity assay for calcineurin phosphatase activity. J Biomol Screening 1997, 2:19-23.
17. De Serres M, McNulty MJ, Christensen L, Zon G, Findlay JWA: Development of a novel scintillation proximity competitive hybridization assay for the determination of phosphorothioate antisense oligonucleotide plasma concentrations in a toxicokinetic study. Anal Biochem 1996, 233:228-233.
18. Sonatore LM, Wisniewski D, Frank LJ, Cameron PM, Hermes JD, Marcy AI, Salowe SP: The utility of FK506-binding protein as a fusion partner in scintillation proximity assays: application to SH2 domains. Anal Biochem 1996, 240:289-297.
19. syk. J Biol Chem 1996, 271:25308-25315.
20. Patel S, Harris A, O'Beirne G, Cook ND, Taylor CW: Kinetic Analysis of inositol triphosphate binding to pure inositol triphosphate receptors using scintillation proximity assay. Biochem Biophys Res Commun 1996, 221:821-825.
21. Fox S: Heralding a new era of cell-based assays. Pharm Forum 1996, 6:1-3.
22. Harris DW, Kenrick MK, Pither RJ, Anson JG, Jones DA: Development of a high volume in situ mRNA hybridization assay for the quantification of gene expression utilizing scintillating microplates. Anal Biochem 1996, 243:249-256. A unique application of scintillation proximity assay using scintillating microplates to quantify mRNA in situ. This method detects mRNA transcripts at the level of 10-20 copies/cell, and is 20-fold more sensitive than Northern blotting. The authors demonstrate the utility of a high throughput approach to quantify gene expression.
23. Brown MP, Royer C: Fluorescence spectroscopy as a tool to investigate protein interactions. Curr Opin Biotechnol 1997, 8:45-49.
24. Glazer AN: Recent advances in fluorescence labeling, detection and visualization. BioRadiations 1997, 98:4-8. A good review of the fundamentals of fluorescence techniques for biological measurements. Detection techniques described are easily amenable to high-thoroughput screening assays. A section on recent advances describe developments in fluorescence resonance energy transfer (FRET) and fluorescence in situ hybridization (FISH) technologies, membrane potential measurements and karyotyping human chromosomes. Over 40 references are cited on various applications.
25. Czarnik AW: Desperately seeking sensors. Chem Biol 1995, 2:423-428.
26. Wang GT, Matayoshi E, Huffaker JE, Krafft GA: Design and synthesis of new fluorogenic HIV protease substrates based on resonance energy transfer. Tetrahedron Lett 1991, 31:6493-6496.
27. Mathis G: Probing molecular interactions with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer. Clin Chem 1995, 41:1391-1397.
28. Kolb JM, Yamanaka G, Manly SP: Use of a novel homogeneous fluorescent technology in high throughput screening. J Biomol Screening 1996, 1:203-210.
29. Gonzalez JE, Tsien RY: Voltage sensing by fluorescence resonance energy transfer. Biophys J 1995, 69:1272-1280.
30. 2+, pH and membrane potential.
31. Waggoner A, Taylor L, Seadler A, Dunlay T: Multiparameter fluorescence imaging microscopy: reagents and instruments. Hum Pathol 1996, 27:494-502.
32. Jameson DM, Sawyer WH: Fluorescence anisotropy applied to biomolecular interactions. Methods Enzymol 1995, 246:283-300.
33. Lundblad JR, Laurance M, Goodman RH: Fluorescence polarization analysis of protein-protein interactions. Mol Endocrinol 1996, 10:607-612.
34. Checovich WJ, Bolger RE, Burke T: Fluorescence polarization - a new tool for cell and molecular biology. Nature 1995, 375:254-256.
35. Levine LM, Michener ML, Toth MV, Holwerda BC: Measurement of specific protease activity utilizing fluorescence polarization. Anal Biochem 1997, 247:83-88. This is the first report describing the use of fluorescence polarization in a high-throughput mode using a modified 96-well plate reader. The peptide substrate for the human cytomegalovirus protease was labeled with biotin and DTAF (5-4,6-dichlorotriazin-2-yl]amino)fluorescein). The uncleaved substrate, when bound to avidin, produced a high polarization value; hence, the presence of inhibitors in the mixture can be easily identified.
36. Jolley ME: Fluorescence polarization assays for the detection of proteases and their inhibitors. J Biomol Screening 1996, 1:33-38.
37. Schade SZ, Jolley ME, Sarauer BJ, Simonson LG: BODIPY-α-Casein, a pH-independent protein substrate for protease assays using fluorescence polarization. Anal Biochem 1996, 243:1-7.
38. Lynch BA, Loiacono LA, Tiong CL, Adams SE, MacNeil IA: A fluorescence polarization based Src-SH2 binding assay. Anal Biochem 1997, 247:77-82. Application of fluorescence polarization in a high-throughput mode to a protein-peptide interaction assay involving Src-SH2 domain. Carboxyfluorescein without a linker was used as the label for the peptide probe to minimize propeller effect. The assay tolerated up to 20% dimethyl sulfoxide (DMSO), a common solvent used to dissolve compounds tested in high-throughput screening.
39. Sterrer S, Henco K: Fluorescence correlation spectroscopy (FCS) - A highly sensitive method to analyze drug/target interactions. J Recept Signal Transduct Res 1997, 17:511-520. This paper describes the use of fluorescence correlation spectroscopy to measure molecular interactions in a homogeneous mode. It has been developed to accommodate measurements in 96- and 384-well microtiter plates, and is a good candidate for high-throughput screening applications.
40. Rigler R: Fluorescence correlations, single molecule detection and large number screening. Applications in biotechnology. J Biotechnol 1995, 41:177-186.
41. Rauer B, Neumann E, Widengren J, Rigler R: Fluorescence correlation spectrometry of the interaction kinetics of tetramethylrhodamine α-bungarotoxin with Torpedo californica acetylcholine receptor. Biophys Chem 1996, 58:3-12.
42. Sarubbi E, Yanofsky SD, Barrett RW, Denaro M: A cell-free, nonisotopic, high-throughput assay for inhibitors of type-1 interleukin-1 receptor. Anal Biochem 1996, 237:70-75.
43. Rose P, Gorman J, Kurtz S, Patel P, Fernandes P: The successful partnership of biotechnology based screen development with high throughput screening. Network Science 1996, 2(Sept):1-12. On the World Wide Web URL: http//www.awod.com/netsci/science/Screening/featureob/html A comprehensive review of cell-based assay systems available for high-throughput screening applications. Targets reviewed include ion channels, G-protein-coupled receptors, tyrosine kinase receptors, intracellular receptors, protein-protein interactions and proteases. Over 40 references are cited.
44. Dhundale A, Goddard C: Reporter assays in high throughput screening laboratory: A rapid and robust first look? J Biomol Screening 1996, 1:115-118.
45. Suto CM, Ignar DM: Selection of an optimal reporter gene for cell-based high throughput screening assays. J Biomol Screening 1997, 2:7-9.
46. Bronstein I, Fortin J, Stanley PE, Stewart GSAB, Kricka LJ: Chemiluminescent and bioluminescent reporter gene assays. Anal Biochem 1994, 219:169-181.
47. Hastings WJ: Chemistries and colors of bioluminescent reactions: a review. Gene 1996, 173:5-11.
48. Lehel C, Daniel-Issakani S, Brasseur M, Strulovici B: A Chemiluminescent microplate assay for sensitive detection of protein kinase activity. Anal Biochem 1997, 244:340-346.
49. Kolb AJ, Neumann K: Luciferase measurements in high throughput screening. J Biomol Screening 1996, 1:85-88.
50. Bran MR, Messier T, Dorman C, Lannigan D: Cell-based assays for G-protein-coupled/Tyrosine kinase coupled receptors. J Biomol Screening 1996, 1:43-45.
51. Rizzuto R, Brini M, De Giorgi F, Rossi R, Heim R, Tsien RY, Pozzan T: Double labelling subcellular structures with organelle-targeted GFP mutants in vivo. Curr Biol 1996, 6:183-188.
52. Janzen B, Domanico P: The 384-well plate: pros and cons. J Biomol Screening 1996, 1:63-64.
53. Lutz MW, Menius A, Choi TD, Laskody RG, Domanico PL, Goetz AS, Saussy DL: Experimental design for high-throughput screening. Drug Discov Tech 1996, 1:277-286.
54. Klein RD, Geary GG: Recombinant microorganisms as tools for high throughput screening for non antibiotic compounds. J Biomol Screening 1997, 2:41-49.
55. Webb SA, Hurskainen P: Transcription-specific assay for quantifying mRNA: A potential replacement for reporter gene assays. J Biomol Screening 1996, 1:119-121.
56. Charych DH, Nagy JO, Spevak W, Bednarski MD: Direct colorimetric detection of receptor-ligand interaction by a polymerized bilayer assembly. Science 1993, 261:585-588.
57. Charych D, Cheng Q, Reichert A, Kuziemko G, Stroh M, Nagy JO, Spevak W, Stevens RC: A 'litmus test' for molecular recognition using artificial membranes. Chem Biol 1996, 3:113-120. A unique, membrane-based colorimetric system that detects molecular interactions is described. Gangliosides that specifically bind cholera toxin, Escherichia coli enterotoxin and botulism neurotoxin were incorporated into a polydiacetylene membrane. The polymerized membrane containing gangliosides is blue, and turns red when the toxin is added. The response is sensitive, specific and selective. An excellent technology for high-throughput screening applications.
58. Spevak W, Foxall C, Charych DH, Dasgupta F, Nagy JO: Carbohydrates in an acidic multivalent assembly: nanomolar P-selectin inhibitors. J Med Chem 1996, 38:1018-1020.
59. Allen S, Davies MC, Roberts CJ, Tendler SJB, Williams PM: Atomic force microscopy in analytical biotechnology. Trends Biotechnol 1997, 15:101-105.
60. Troy CT, Abrams SB: Scanning force microscopy helps in the design of cancer drugs. Biophoton Int 1996, Sept/Oct:52-53.
61. Paborsky LR, Dunn KE, Gibbs CS, Dougherty JP: A nickel chelate microtiter plate assay for six histidine-containing proteins. Anal Biochem 1996, 234:60-65.
62. Weiss-Wichert CH, Smetazko M, Valina-saba M, Schalkhammer TH: A new analytical device based on gated ion channels: A peptide channel biosensor. J Biomol Screening 1997, 2:11-18.
63. Brecht A, Burckardt R, Rickert J, Stemmler I, Schuetz A, Fischer S, Friedrich T, Gauglitz G, Goepel W: Transducer-based approaches for parallel binding assays in HTS. J Biomol Screening 1996, 1:191-201.
64. Tyagi S, Kramer FR: Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 1996, 14:303-308.
65. Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW: Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sd USA 1997, 94:2150-2155.
66. Nicolaou KC, Xiao XY, Parandoosh Z, Senyei A, Nova MP: Radiofrequency encoded combinatorial chemistry. Angew Chem Int Ed 1995, 34:2289-2291.
67. Fitzgerald MC, Harris K, Shevlin CG, Siuzdak G: Direct characterization of solid phase resin-bound molecules by mass spectrometry. Bioorg Med Chem Lett 1996, 6:979-982.
68. Chu YH, Dunnayevskiy YM, Kirby DP, Vouros P, Karger BL: Affinity capillary electrophoresis-mass spectrometry for screening combinatorial libraries. J Am Chem Soc 1996, 118:7827-7835.
69. Evans DM, Williams KP, McGuinness B, Tarr G, Regnier F, Afeyan N, Jindal S: Affinity-based screening of combinatorial libraries using automated, serial-column chromatography. Nat Biotechnol 1996, 14:504-507.